Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ February 3, 2023 ] This February, Stay “Hy” and Spread the Love with Essential Elements Los Angeles Biotech News
  • [ February 3, 2023 ] Poland’s SatRev Signs On for Future Virgin Orbit Flights Los Angeles Biotech News
  • [ February 3, 2023 ] Maternal Mental Health Organization Shares Postpartum Psychosis Symptom Checklist in Response to Recent Postpartum Psychosis Tragedies Los Angeles Biotech News
  • [ February 3, 2023 ] Postdoctoral Fellow – Computational Biology, Computational Chemistry, Bioinformatics – City of Hope – Duarte, CA Los Angeles Biotech Jobs
  • [ February 3, 2023 ] Research Associate – AdvanBio – Irvine, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsArrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890

Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890

July 29, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Amgen pays Arrowhead $20 million milestone for start of Phase 2 study of AMG 890 formerly ARO-LPA

Click to view original post

Previous

Xencor to Host Second Quarter 2020 Financial Results Webcast and Conference Call on August 4, 2020

Next

Emmaus Life Sciences Receives Scientific Advice From the EMA Regarding Xyndari™

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered